Insider · CIK 0001245926
David Dantzker
Files at SRDX (SURMODICS INC). First filing -, latest -.
In brief
David Dantzker files SEC Form 4 as director at SRDX (SURMODICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Dantzker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | SRDX SURMODICS INC | DDisposition to issuer Common Stock | -40,183 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | SRDX SURMODICS INC | DDisposition to issuer Employee Stock Option (right to buy)derivative | -2,605 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | SRDX SURMODICS INC | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,218 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | SRDX SURMODICS INC | DDisposition to issuer Employee Stock Options (right to buy)derivative | -2,964 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | SRDX SURMODICS INC | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,555 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | SRDX SURMODICS INC | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,674 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | SRDX SURMODICS INC | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,853 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Feb 13, 2025 | SRDX SURMODICS INC | MOption exercise Common Stock | +5,275 | $27.30 | $144k | 44,399 | Feb 18, 2025 |
| Feb 13, 2025 | SRDX SURMODICS INC | FTax withholding Common Stock | -4,216 | $34.16 | $144k | 40,183 | Feb 18, 2025 |
| Feb 13, 2025 | SRDX SURMODICS INC | MOption exercise Stock Option (right to buy)derivative | -5,275 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 8, 2024 | SRDX SURMODICS INC | AGrant or award Common Stock | +1,803 | $0.00 | $0 | 39,124 | Feb 12, 2024 |
| Feb 8, 2024 | SRDX SURMODICS INC | AGrant or award Stock Option (right to buy)derivative | +3,853 | $0.00 | $0 | 3,853 | Feb 12, 2024 |
| Jan 19, 2024 | SRDX SURMODICS INC | MOption exercise Common Stock | +3,932 | $23.95 | $94k | 40,094 | Jan 23, 2024 |
| Jan 19, 2024 | SRDX SURMODICS INC | FTax withholding Common Stock | -2,773 | $33.97 | $94k | 37,321 | Jan 23, 2024 |
| Jan 19, 2024 | SRDX SURMODICS INC | MOption exercise Stock Option (right to buy)derivative | -3,932 | $0.00 | $0 | 0 | Jan 23, 2024 |
Questions about David Dantzker
Answered from the filings on this page, as of the latest one.
Is David Dantzker buying or selling?
David Dantzker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Dantzker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Dantzker has 0.
Where does David Dantzker file Form 4?
David Dantzker has filed Form 4 at SRDX (SURMODICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.